Transglutaminases in inflammation and fibrosis of the gastrointestinal tract and the liver

被引:73
作者
Elli, L. [1 ]
Bergamini, C. M. [2 ]
Bardella, M. T. [1 ,3 ]
Schuppan, D. [4 ,5 ]
机构
[1] Fdn IRCCS Osped Maggiore Policlin, Ctr Prevent & Diag Celiac Dis, Milan, Italy
[2] Univ Ferrara, Dept Biochem, I-44100 Ferrara, Italy
[3] Univ Milan, Dept Med Sci, Milan, Italy
[4] Beth Israel Deaconess Med Ctr, Boston, MA 02215 USA
[5] Harvard Univ, Sch Med, Boston, MA USA
关键词
Celiac disease; Collagen; Crohn's disease; Extracellular matrix; Gliadin; Inflammatory bowel disease; NFkB; Ulcerative colitis; CROSS-LINKING ENZYMES; HUMAN TISSUE TRANSGLUTAMINASE; GTP-BINDING PROTEIN; CELIAC-DISEASE; RETINOIC ACID; BOWEL-DISEASE; FACTOR-XIII; ANTITISSUE TRANSGLUTAMINASE; SERUM TRANSGLUTAMINASE; SELECTIVE INHIBITORS;
D O I
10.1016/j.dld.2008.12.095
中图分类号
R57 [消化系及腹部疾病];
学科分类号
100201 [内科学];
摘要
Transglutaminases are a family of eight currently known calcium-dependent enzymes that catalyze the cross-linking or deamidation of proteins. They are involved in important biological processes such as wound healing, tissue repair, fibrogenesis, apoptosis, inflammation and cell-cycle control. Therefore, they play important roles in the pathomechanisms of autoimmune, inflammatory and degenerative diseases, many of which affect the gastrointestinal system. Transglutaminase 2 is prominent, since it is central to the pathogenesis of celiac disease, and modulates inflammation and fibrosis in inflammatory bowel and chronic liver diseases. This review highlights our present understanding of transglutaminase function in gastrointestinal and liver diseases and therapeutic strategies that target transglutaminase activities. (c) 2008 Editrice Gastroenterologica Italiana S.r.l. Published by Elsevier Ltd. All rights reserved.
引用
收藏
页码:541 / 550
页数:10
相关论文
共 159 条
[1]
AESCHLIMANN D, 1994, THROMB HAEMOSTASIS, V71, P402
[2]
Phosphoinositide 3-kinase activity is required for retinoic acid-induced expression and activation of the tissue transglutaminase [J].
Antonyak, MA ;
Boehm, JE ;
Cerione, RA .
JOURNAL OF BIOLOGICAL CHEMISTRY, 2002, 277 (17) :14712-14716
[3]
Effects of tissue transglutaminase on retinoic acid-induced cellular differentiation and protection against apoptosis [J].
Antonyak, MA ;
Singh, US ;
Lee, DA ;
Boehm, JE ;
Combs, C ;
Zgola, MM ;
Page, RL ;
Cerione, RA .
JOURNAL OF BIOLOGICAL CHEMISTRY, 2001, 276 (36) :33582-33587
[4]
The protective effects of cystamine in the R6/2 Huntington's disease mouse involve mechanisms other than the inhibition of tissue transglutaminase [J].
Bailey, Craig D. C. ;
Johnson, Gail V. W. .
NEUROBIOLOGY OF AGING, 2006, 27 (06) :871-879
[5]
Immunopathogenesis of inflammatory bowel disease: current concepts [J].
Bamias, Giorgos ;
Cominelli, Fabio .
CURRENT OPINION IN GASTROENTEROLOGY, 2007, 23 (04) :365-369
[6]
Serological markers for coeliac disease: is it time to change? [J].
Bardella, MT ;
Trovato, C ;
Cesana, BM ;
Pagliari, C ;
Gebbia, C ;
Peracchi, M .
DIGESTIVE AND LIVER DISEASE, 2001, 33 (05) :426-431
[7]
REGULATION OF INTESTINAL EPITHELIAL-CELL GROWTH BY TRANSFORMING GROWTH-FACTOR TYPE-BETA [J].
BARNARD, JA ;
BEAUCHAMP, RD ;
COFFEY, RJ ;
MOSES, HL .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1989, 86 (05) :1578-1582
[8]
Cellular differentiation and death in a renaissance castle [J].
C M Bergamini ;
R L Eckert ;
A Ichinose ;
L Muszbek ;
M Squerzanti .
Cell Death & Differentiation, 2003, 10 (2) :262-265
[9]
IgA and IgG tissue transglutaminase antibody prevalence and clinical significance in connective tissue diseases, inflammatory bowel disease, and primary biliary cirrhosis [J].
Bizzaro, N ;
Villalta, D ;
Tonutti, E ;
Doria, A ;
Tampoia, M ;
Bassetti, D ;
Tozzoli, R .
DIGESTIVE DISEASES AND SCIENCES, 2003, 48 (12) :2360-2365
[10]
Tissue transglutaminase protects against apoptosis by modifying the tumor suppressor protein p110 Rb. [J].
Boehm, JE ;
Singh, U ;
Combs, C ;
Antonyak, MA ;
Cerione, RA .
JOURNAL OF BIOLOGICAL CHEMISTRY, 2002, 277 (23) :20127-20130